Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

851.75INR
5:43am EDT
Change (% chg)

Rs8.65 (+1.03%)
Prev Close
Rs843.10
Open
Rs845.00
Day's High
Rs851.85
Day's Low
Rs838.00
Volume
286,818
Avg. Vol
606,069
52-wk High
Rs1,262.90
52-wk Low
Rs671.10

Latest Key Developments (Source: Significant Developments)

Glenmark Pharma gets ANDA approval for potassium chloride tablets
Tuesday, 26 Jul 2016 10:56pm EDT 

Glenmark Pharmaceuticals Ltd : Receives ANDA approval for potassium chloride extended-release tablets USP, 10 MEQ (750 mg) and 20 MEQ (1500 mg) .  Full Article

Glenmark Pharma Closes $200 mln bond issue
Tuesday, 26 Jul 2016 12:07am EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals announces the successful closure of its USD 200 mln Reg S USD Bond . The bonds were oversubscribed 8 times . Proceeds will be used for investment in units abroad and repay debt .  Full Article

Glenmark Pharma gets FDA nod for generic triamcinolone acetonide ointment
Sunday, 24 Jul 2016 11:04pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark Pharmaceuticals receives ANDA approval for triamcinolone acetonide ointment USP, 0.5% .  Full Article

Glenmark Pharma to raise $200 mln via issue of USD bonds
Sunday, 17 Jul 2016 10:55pm EDT 

Glenmark Pharmaceuticals Ltd : Glenmark pharmaceuticals ltd.- plans to issue a usd denominated international bond for repaying its existing debt . Glenmark pharmaceuticals ltd.- the net proceeds will be used for repaying the existing debt. . Glenmark pharmaceuticals ltd.- planning to raise around USD 200 million by issuing usd denominated non-convertible unsecured bonds . Glenmark pharmaceuticals ltd.- bonds are planned to be listed on the Singapore stock exchange ` .  Full Article

Glenmark Pharmaceuticals receives ANDA approval for Nystatin And Triamcinolone Acetonide ointment
Thursday, 23 Jun 2016 11:16pm EDT 

Glenmark Pharmaceuticals Ltd : Receives anda approval for nystatin and triamcinolone acetonide ointment usp, 100,000 units/1 mg per gram .  Full Article

Nanorepro starts cooperation with Glenmark in South Africa
Wednesday, 25 May 2016 02:30am EDT 

Nanorepro AG : Starts cooperation with a multinational pharmaceutical company Glenmark in South Africa . Cooperation starts with eight OTC tests and two tests for the medical use .After a successful pilot project option for exclusive distribution agreement.  Full Article

Glenmark Pharmaceuticals gets ANDA approval for rufinamide tablets
Wednesday, 18 May 2016 10:57pm EDT 

Glenmark Pharmaceuticals Ltd : Receives ANDA approval for rufinamide tablets usp, 200 mg and 400 mg .  Full Article

Glenmark Pharmaceuticals March-quarter consol net profit rises
Thursday, 12 May 2016 08:15am EDT 

Glenmark Pharmaceuticals Ltd : India's Glenmark Pharmaceuticals - March-quarter consol net profit 1.43 billion rupees versus net profit of 106.1 million rupees year ago . Says March-quarter consol net sales 22.89 billion rupees versus 17.54 billion rupees year ago . Recommended dividend of inr 2 per share .  Full Article

Glenmark Pharmaceuticals Ltd receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg
Tuesday, 23 Feb 2016 11:37pm EST 

Glenmark Pharmaceuticals Ltd:Says that it has receives ANDA approval for Norgestimate and Ethinyl Estradiol Tablets USP, 0.18 g/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, the generic version of Orthi Tri-Cyclen Lo Tablets of Janssen Pharmaceuticals Inc.  Full Article

Glenmark Pharmaceuticals receives tentative ANDA approval for Azelaic Acid Gel, 15%
Tuesday, 16 Feb 2016 10:45pm EST 

Glenmark Pharmaceuticals Ltd:Says Glenmark Pharmaceuticals Inc., USA has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for its Azelaic Acid Gel, 15%, generic version of Finacea Topical Gel, 15% of Bayer Healthcare.Says Glenmark will market this product upon receiving final approval of its Azelaic Acid Gel, 15% ANDA.Says patent listed in the Orange Book for Finacea Topical Gel, 15% is scheduled to expire on Nov. 18, 2018.  Full Article

Fitch Assigns First-Time 'BB' Rating to Glenmark Pharmaceuticals

(The following statement was released by the rating agency) SINGAPORE/MUMBAI, July 18 (Fitch) Fitch Ratings has assigned India-based Glenmark Pharmaceuticals Ltd (Glenmark) a Long-Term Foreign-Currency Issuer Default Rating (IDR) of 'BB'. The Outlook is Positive. Fitch has also assigned Glenmark's proposed Reg S notes an expected rating of 'BB(EXP)'. Glenmark's rating incorporates its geographically diversified profile, a demonstrated track record in regulatory compliance and its healthy pr